{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:19:50Z","timestamp":1790716790562,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004375","name":"Tel Aviv University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004375","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.anai.2022.12.001","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T02:05:28Z","timestamp":1670551528000},"page":"340-346.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Factors associated with home epinephrine-treated reactions during peanut and tree-nut oral immunotherapy"],"prefix":"10.1016","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4377-472X","authenticated-orcid":false,"given":"Liat","family":"Nachshon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naama","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naama","family":"Epstein-Rigbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitzhak","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon","family":"Elizur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.anai.2022.12.001_bib0001","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11882-016-0602-0","article-title":"The heterogeneity of Oral Immunotherapy clinical trials: implications and future directions","volume":"16","author":"Yee","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"issue":"3","key":"10.1016\/j.anai.2022.12.001_bib0002","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1200435","article-title":"Oral immunotherapy for treatment of egg allergy in children","volume":"367","author":"Burks","year":"2012","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.anai.2022.12.001_bib0003","first-page":"1991","article-title":"AR101 oral immunotherapy for peanut allergy","volume":"397","author":"Vickery","year":"2018","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.anai.2022.12.001_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2020.03.043","article-title":"Peanut oral immunotherapy protects patients from accidental allergic reactions to peanut","volume":"8","author":"Trendelenburg","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2022.12.001_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2018.06.016","article-title":"Quality of life of food-allergic patients before, during and following oral immunotherapy","volume":"7","author":"Epstein-Rigbi","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10","key":"10.1016\/j.anai.2022.12.001_bib0006","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1111\/all.14350","article-title":"Quality of life of children aged 8-12 years undergoing food allergy oral immunotherapy: child and parent perspective","volume":"75","author":"Epstein-Rigbi","year":"2020","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.anai.2022.12.001_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2021.02.046","article-title":"An approach to the office-based practice of food oral immunotherapy","volume":"9","author":"Wasserman","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"10.1016\/j.anai.2022.12.001_bib0008","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1016\/j.jaip.2020.03.016","article-title":"Community private practice clinical experience with peanut oral immunotherapy","volume":"8","author":"Afinogenova","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10187","key":"10.1016\/j.anai.2022.12.001_bib0009","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/S0140-6736(19)30420-9","article-title":"Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety","volume":"393","author":"Chu","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.anai.2022.12.001_bib0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jaip.2021.10.070","article-title":"Advances, practical implementation and unmet needs regarding oral immunotherapy for food allergy","volume":"10","author":"Perrett","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2022.12.001_bib0011","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jaci.2016.07.030","article-title":"Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy","volume":"139","author":"Virkud","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2022.12.001_bib0012","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.anai.2014.07.010","article-title":"Life-threatening anaphylaxis to egg and milk oral immunotherapy in asthmatic teenagers","volume":"113","author":"Vazquez-Ortiz","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2022.12.001_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2020.07.034","article-title":"Patient characteristics and risk factors for home epinephrine-treated reactions during oral immunotherapy for food allergy","volume":"9","author":"Nachshon","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2022.12.001_bib0014","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11882-020-0898-7","article-title":"Epidemiology and burden of food allergy","volume":"20","author":"Warren","year":"2020","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.anai.2022.12.001_bib0015","unstructured":"National Food Death Allergy Registry. The Registry. Available at: https:\/\/www.nationalfoodallergydeathregistry.org\/the-registry. Accessed May 1, 2022."},{"issue":"12","key":"10.1016\/j.anai.2022.12.001_bib0016","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/cea.13287","article-title":"Food-induced fatal anaphylaxis: from epidemiological data to general prevention strategies","volume":"48","author":"Pouessel","year":"2018","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"10.1016\/j.anai.2022.12.001_bib0017","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jaci.2007.01.021","article-title":"Further fatal allergic reactions to food in the United Kingdom, 1999-2006","volume":"119","author":"Richard","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2022.12.001_bib0018","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jaci.2021.03.048","article-title":"Global patterns in anaphylaxis due to specific foods: a systematic review","volume":"148","author":"Conrado","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2022.12.001_bib0019","unstructured":"US Food and Drug Administration. FDA approves first drug for treatment of peanut allergy for children. 2020. Available at: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-drug-treatment-peanut-allergy-children. Accessed May 1, 2022."},{"issue":"1","key":"10.1016\/j.anai.2022.12.001_bib0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jaip.2020.11.008","article-title":"Irradiated tree nut flours for use in oral immunotherapy","volume":"9","author":"Penumarti","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2022.12.001_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2013.10.001","article-title":"Clinical predictors for favorable outcomes in an oral immunotherapy program for IgE-mediated cow's milk allergy","volume":"112","author":"Levy","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.anai.2022.12.001_bib0022","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/pai.12914","article-title":"Long-Term outcome of Peanut Oral Immunotherapy - real Life Experience","volume":"29","author":"Nachshon","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"issue":"8","key":"10.1016\/j.anai.2022.12.001_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2019.05.031","article-title":"Efficacy and Safety of Sesame oral immunotherapy - a real-world, single center study","volume":"7","author":"Nachshon","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2022.12.001_bib0024","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S2352-4642(19)30029-X","article-title":"Walnut oral immunotherapy for desensitisation of walnut and additional tree nut allergies (Nut CRACKER): a single-centre, prospective cohort study","volume":"3","author":"Elizur","year":"2019","journal-title":"Lancet Child Adolesc Health"},{"issue":"6","key":"10.1016\/j.anai.2022.12.001_bib0025","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1111\/all.15212","article-title":"Cashew oral immunotherapy for desensitizing cashew-pistachio allergy (NUT CRACKER study)","volume":"77","author":"Elizur","year":"2022","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.anai.2022.12.001_bib0026","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2020.01.017","article-title":"Anaphylaxis\u2013a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis","volume":"145","author":"Shaker","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2022.12.001_bib0027","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2009.10.060","article-title":"Speaking the same language: the World Allergy Organization subcutaneous Immunotherapy Systemic Reaction Grading System","volume":"125","author":"Cox","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.anai.2022.12.001_bib0028","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/pai.12961","article-title":"Quantitative risk reduction through peanut immunotherapy: safety benefits of an increased threshold in Europe","volume":"29","author":"Remington","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"10.1016\/j.anai.2022.12.001_bib0029","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jaip.2016.12.004","article-title":"Immunotherapy for food allergy: are we there yet?","volume":"5","author":"Gernez","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2022.12.001_bib0030","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.anai.2019.09.001","article-title":"ICER report for peanut OIT comes up short","volume":"123","author":"Eiwegger","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.anai.2022.12.001_bib0031","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.anai.2015.04.007","article-title":"A web site-based reporting system for monitoring home treatment during oral immunotherapy for food allergy","volume":"114","author":"Nachshon","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.anai.2022.12.001_bib0032","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2017.06.031","article-title":"Fatal anaphylaxis: mortality rate and risk factors","volume":"5","author":"Turner","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2022.12.001_bib0033","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaci.2020.06.033","article-title":"Cardiovascular changes during peanut-induced allergic reactions in human subjects","volume":"147","author":"Ruiz-Garcia","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2022.12.001_bib0034","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/all.13353","article-title":"NUT Co Reactivity - ACquiring Knowledge for Elimination Recommendations (nut cracker) study","volume":"73","author":"Elizur","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2022.12.001_bib0035","unstructured":"Mondello W. Girl with milk allergy dies of severe reaction related to desensitization. 2021. Available at: https:\/\/www.allergicliving.com\/2021\/12\/20\/girl-with-milk-allergy-dies-of-severe-reaction-related-to-desensitization. Accessed May 1, 2022."},{"issue":"5","key":"10.1016\/j.anai.2022.12.001_bib0036","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.jaip.2020.12.025","article-title":"A high proportion of Canadian allergists offer oral immunotherapy but barriers remain","volume":"9","author":"Mack","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2022.12.001_bib0037","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/all.14683","article-title":"Peanut-induced anaphylaxis in children and adolescents: data from the European Anaphylaxis Registry","volume":"76","author":"Maris","year":"2021","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2022.12.001_bib0038","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jaip.2021.10.008","article-title":"Fatal food anaphylaxis: distinguishing fact from fiction","volume":"10","author":"Anagnostou","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2022.12.001_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2021.05.013","article-title":"Differences in oral food challenge reaction severity based on increasing age in a pediatric population","volume":"127","author":"Kennedy","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2022.12.001_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.10.021","article-title":"Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012","volume":"135","author":"Turner","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.anai.2022.12.001_bib0041","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1111\/all.15318","article-title":"Risk factors for severe reactions in food allergy: rapid evidence review with meta-analysis","volume":"77","author":"Turner","year":"2022","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.anai.2022.12.001_bib0042","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1398-9995.2007.01447.x","article-title":"Cashew nut causes more severe reactions than peanut: case-matched comparison in 141 children","volume":"62","author":"Clark","year":"2007","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.anai.2022.12.001_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2015.11.015","article-title":"Anaphylaxis in children and adolescents: the European Anaphylaxis Registry","volume":"137","author":"Grabenhenrich","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2022.12.001_bib0044","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/all.13810","article-title":"Food allergy endotype with high risk of severe anaphylaxis in children-Monosensitization to cashe 2S albumin Ana o 3","volume":"74","author":"Blazowski","year":"2019","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2022.12.001_bib0045","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2045-7022-4-4","article-title":"Oil body-associated hazelnut allergens including oleosins are underrepresented in diagnostic extracts but associated with severe symptoms","volume":"4","author":"Zuidmeer-Jongejan","year":"2014","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.anai.2022.12.001_bib0046","unstructured":"US Department of Agriculture. FoofData Central. Available at: https:\/\/fdc.nal.usda.gov. Accessed May 1, 2022."},{"issue":"4","key":"10.1016\/j.anai.2022.12.001_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2021.05.008","article-title":"Home epinephrine-treated reactions in food allergy oral immunotherapy: lessons from COVID-19 lockdown","volume":"127","author":"Nachshon","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2022.12.001_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2021.12.023","article-title":"Triggers for home epinephrine-treated reactions during oral immunotherapy for food allergy","volume":"10","author":"Nachshon","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2022.12.001_bib0049","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s40521-019-00205-2","article-title":"Risk factors for adverse reactions during OIT","volume":"6","author":"Patel","year":"2019","journal-title":"Curr Treat Options Allergy"},{"issue":"3","key":"10.1016\/j.anai.2022.12.001_bib0050","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jaci.2009.06.025","article-title":"Open-label maintenance after milk oral immunotherapy for IgE-mediated cow's milk allergy","volume":"124","author":"Narisety","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2022.12.001_bib0051","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/all.12794","article-title":"Clinical and laboratory 2-year outcome of oral immunotherapy in patients with cow's milk allergy","volume":"71","author":"Elizur","year":"2016","journal-title":"Allergy"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120622019718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120622019718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:31:42Z","timestamp":1761053502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120622019718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1081120622019718"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2022.12.001","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with home epinephrine-treated reactions during peanut and tree-nut oral immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2022.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}